Simultaneous transplantation and intrathymic tolerance induction. A method with clinical potential.
It has been shown that donor-specific tolerance to cardiac allografts can be induced by pretreating the prospective recipient with injections of donor splenocytes (intrathymically) and antilymphocyte serum (intraperitoneally) weeks or days before the actual transplantation. This procedure, however, lacks clinical relevance in the case of cadaver donors due to the obligatory interval between the start of the tolerance induction protocol and transplantation. We have tried to devise a protocol in which this interval is eliminated, thus allowing allotransplantation simultaneously with tolerance induction. Our results show that simultaneous cardiac allotransplantation and intrathymic tolerance induction by intrathymic injection of donor splenocytes and treatment with antilymphocyte serum is indeed possible in the PVG to AO high-responder rat strain combination, provided that low doses of cyclosporine are given intramuscularly on day 1, 2, and 3 after transplantation. As we now are able to combine the start of tolerance induction with the actual allotransplantation, this procedure may indeed have clinical potential.
Department of Histology and Cell Biology, University of Groningen, The Netherlands.
F A
FA
Klatter
H P
HP
Raué
H L
HL
Bartels
J M
JM
Pater
H
H
Groen
P
P
Nieuwenhuis
J
J
Kampinga
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D016027:Heart Transplantation / Q000276:immunology*; D007108:Immune Tolerance; D007165:Immunosuppression Therapy / Q000379:methods*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000166:cytology / Q000276:immunology*; D013950:Thymus Gland / Q000276:immunology*; D013997:Time Factors; D014019:Tissue Donors
D000961:Antilymphocyte Serum